Shrivastava S, Chen B, Dworkin L, Malhotra D, Gong R
Am J Nephrol. 2020; 51(5):390-394.
PMID: 32187600
PMC: 7521046.
DOI: 10.1159/000506854.
LANDON J
J R Coll Physicians Lond. 2019; 2(3):259-269.
PMID: 30667781
PMC: 5370714.
Wang P, Zhang Y, Wang Y, Brem A, Liu Z, Gong R
Pediatrics. 2017; 140(1).
PMID: 28642375
PMC: 5495526.
DOI: 10.1542/peds.2016-2169.
Haddad Jr J, CALDWELL J
J Clin Invest. 1972; 51(12):3133-41.
PMID: 4674398
PMC: 332995.
DOI: 10.1172/JCI107140.
Hodges J, Mitchley S
Br J Pharmacol. 1971; 43(4):804-13.
PMID: 4339886
PMC: 1665719.
DOI: 10.1111/j.1476-5381.1971.tb07216.x.
Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. II. Zinc tetracosactrin (Depot Synacthen).
Glass D, Nuki G, Daly J
Ann Rheum Dis. 1971; 30(6):593-6.
PMID: 4331739
PMC: 1005835.
DOI: 10.1136/ard.30.6.593.
Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. I. Porcine ACTH.
Glass D, Daly J
Ann Rheum Dis. 1971; 30(6):589-92.
PMID: 4331738
PMC: 1005834.
DOI: 10.1136/ard.30.6.589.
Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth.
Zutshi D, Friedman M, ANSELL B
Arch Dis Child. 1971; 46(249):584-93.
PMID: 4330191
PMC: 1647856.
DOI: 10.1136/adc.46.249.584.
Hypothalamic-pituitary-adrenal function in patients treated with long-term depot tetracosactrin.
Irvine W, Cullen D, Khan S, Ratcliffe J
Br Med J. 1971; 1(5750):630-6.
PMID: 4323439
PMC: 1795405.
DOI: 10.1136/bmj.1.5750.630.
Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
Glass D, Roffe L, Maini R, WRAITH D, Nuki G
Clin Exp Immunol. 1975; 20(1):55-63.
PMID: 173487
PMC: 1538181.